Primary Job Title Co-Founder & Scientific Advisory Board Member Primary Organization 
CRISPR Therapeutics
Location Basel, Basel-Stadt, Switzerland Regions Europe, Middle East, and Africa (EMEA) Gender Female
LinkedIn View on LinkedIn
Dr. Emmanuelle Charpentier co-founded CRISPR Therapeutics together with Rodger Novak and Shaun Foy. She is Founding, Scientific and Managing Director of the Max Planck Unit for the Science of Pathogens and Honorary Professor at Humboldt University, Berlin, Germany. Prior to joining Max Planck, Emmanuelle was awarded an Alexander von Humboldt
professorship at the Helmholtz Centre for Infection Research in Braunschweig, where she headed the Department of Regulation in Infection Biology, and was a Professor at the Hannover Medical School. For many years, she oversaw research groups at Umeå University in Sweden and the University of Vienna in Austria. She received her education in microbiology, biochemistry and genetics from the University Pierre and Marie Curie and the Pasteur Institute in Paris, France and continued with a post-doctoral training in several academic institutions in New York and Memphis, USA.
